NALCN与UNC80相关疾病的基因型-表型特征
这项横断面研究纳入51例NALCN或UNC80致病/可能致病变异患者,分析CLIFAHDD、IHPRF 1和IHPRF 2综合征的表型谱。功能缺失变异患者发育迟缓更重,喂养困难、中枢性睡眠呼吸暂停和癫痫更常见;CLIFAHDD患者可见远端关节挛缩、发作性共济失调和阵发性肌张力障碍。作者提出若干基因型-表型关联假设,需更大队列验证。
要点
- 功能缺失变异患者神经发育迟缓更严重(p=0.019),喂养困难、中枢性睡眠呼吸暂停和癫痫更常见。
- CLIFAHDD患者中远端关节挛缩(76.5%)、发作性共济失调(41.2%可行走患者)和阵发性肌张力障碍(11.7%)仅见于该亚型。
- 癫痫患者认知延迟更重(p=0.016),58.8%为难治性,起病越早越易难治(p=0.014)。
核心结论
- 远端关节挛缩、发作性共济失调和阵发性肌张力障碍见于CLIFAHDD患者,而喂养困难、中枢性睡眠呼吸暂停和癫痫与功能缺失变异相关。
- 作者提出潜在的基因型-表型关联假设,需未来更大队列研究验证。
研究设计与样本
- 横断面研究,纳入51例NALCN或UNC80致病/可能致病变异患者(CLIFAHDD 34例,IHPRF 1 9例,IHPRF 2 8例;年龄3个月至27岁;女性37.3%)。
- 通过结构化访谈、问卷和病历回顾评估表型,分析变异、临床特征与综合征之间的关联。
主要发现
- 所有患者均表现神经发育延迟,功能缺失变异患者更严重(p=0.019)。
- CLIFAHDD患者中29.4%出现神经发育倒退,与共济失调起病相关(70%)。
- CLIFAHDD患者出生时呼吸症状更重(11.7%行经口气管插管)。
- 功能缺失变异患者更常见喂养困难(88.2%,p=0.001)、中枢性睡眠呼吸暂停(64.7%,p<0.001)和癫痫(70.6%,p<0.001)。
- 癫痫与更严重认知延迟相关(p=0.016),58.8%患者难治;起病越早与难治性癫痫相关(p=0.014)。
关键数值与推荐
- CLIFAHDD患者中远端关节挛缩占76.5%,发作性共济失调占可行走患者的41.2%,阵发性肌张力障碍占11.7%。
- 功能缺失变异患者中喂养困难占88.2%(p=0.001),中枢性睡眠呼吸暂停占64.7%(p<0.001),癫痫占70.6%(p<0.001)。
- CLIFAHDD患者中神经发育倒退占29.4%,其中70%与共济失调起病相关;出生时经口气管插管占11.7%。
- 癫痫患者中难治性占58.8%;癫痫与更严重认知延迟相关(p=0.016);起病越早与难治性癫痫相关(p=0.014)。
- 神经发育延迟在功能缺失变异患者中更严重(p=0.019)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出本研究为提出假设,需未来更大队列研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The NALCN channelosome regulates the resting membrane potential through sodium leak currents, influencing cellular excitability. Genetic variants in NALCN and UNC80, a subunit of the NALCN channelosome, cause ultra-rare and severe neurodevelopmental disorders. Autosomal dominant congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) syndrome is associated with gain-of-function (GOF) variants in NALCN. Infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) 1 syndrome is associated with biallelic variants in NALCN and IHPRF 2 syndrome with biallelic variants in UNC80, both resulting in a loss-of-function (LOF). This study aims to expand the phenotypes associated with these syndromes, exploring potential genotype-phenotype associations. METHODS: This is a cross-sectional study including patients with pathogenic or likely pathogenic variants in NALCN and UNC80. Phenotypes were evaluated through a structured interview, questionnaires, and review of medical records. Associations between variants, clinical features, and syndromes were analyzed. RESULTS: Fifty-one patients were included (34 with CLIFAHDD, 9 with IHPRF 1, 8 with IHPRF 2; 3 months-27 years; 37.3% female). All exhibited neurodevelopmental delay, more severe in patients with LOF variants (p = 0.019). Neurodevelopmental regression was observed in 29.4% of patients with CLIFAHDD syndrome, associated with the onset of ataxia (70%). Patients with CLIFAHDD had more severe respiratory symptoms at birth (11.7% orotracheal intubation). Distal arthrogryposis (76.5%), episodic ataxia (41.2% of ambulatory patients), and paroxysmal dystonia (11.7%) were exclusively diagnosed in patients with CLIFAHDD. Patients with LOF variants presented more frequently with failure to thrive (88.2%, p = 0.001), central sleep apnea (CSA, 64.7%, p < 0.001), and epilepsy (70.6%, p < 0.001). Epilepsy was associated with more severe cognitive delays (p = 0.016) and was refractory in 58.8% of patients. Earlier seizure onset was associated with refractory epilepsy (p = 0.014). Patients with CLIFAHDD and premature death, epilepsy, or paroxysmal dystonia carried variants within NALCN pore domains. DISCUSSION: This study provides an in-depth clinical characterization of NALCN-related and UNC80-related disorders. Distal arthrogryposis, episodic ataxia, and paroxysmal dystonia were diagnosed in patients with CLIFAHDD while failure to thrive, CSA, and epilepsy were associated with LOF variants. We suggest potential genotype-phenotype associations, formulating hypotheses for validation in future studies with larger cohorts.
引用
- Parra-Díaz P, Monteil A, Calame D, et al. Genotype-Phenotype Landscape of NALCN and UNC80-Related Disorders. Neurology. 2025. PMID: 40048676. doi:10.1212/WNL.0000000000213429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。